首页> 美国政府科技报告 >Orthostatic Tolerance During al-Adrenergic Receptor Blockade at High Altitude
【24h】

Orthostatic Tolerance During al-Adrenergic Receptor Blockade at High Altitude

机译:高海拔地区al-adrenergic受体阻滞期间的直立性耐受

获取原文

摘要

In the first two weeks of high altitude (HA) exposure, blood pressure typically rises due, in part, to a large increase in sympathetic stimulation. We hypothesized that blocking al-adrenergic receptors would impair circulatory compensation to an orthostatic challenge to a greater extent at HA than at sea level (SL). Sixteen healthy women (23 +/- 2 yr) were randomly assigned to receive either 2 mg prazosin (n = 8) or placebo (n = S) t.i.d. (double-blind design) for 12 d at SL and during the first 12 d of HA residence (4300 m). Passive & O upright tilt was performed at SL (10 d of treatment), and after 3 and 10 d at HA. Mean arterial blood pressure (MBP, auscultation) and heart rate (HR, ECG) were measured every min during 10 min each of supine rest and tilt. For the prazosin group compared to the placebo group: (1) At SL, supine and tilt MBP were lower (P < 0.05) and, at HA, MBP was lower only in the first several min of tilt on day 10 (P <0.05); (2) At SL or HA, HR was similar for either position; and (3) From supine to tilt, the drop in MBP was greater only at SL and the increase in HR was consistently greater only at HA (both P < 0.05). We conclude that al-adrenergic blockade altered MBP and HR responses to tilt at SL and HA, but that orthostatic tolerance was well maintained in both environments. Compensatory adjustments were likely in either sympathetic and parasympathetic neural discharge or in other receptor activities.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号